An evidence-based exploration of how culinary botanicals synergize with cannabinoids to create pharmacologically active, ...

A study conducted by researchers at the University of Illinois Urbana-Champaign used deep learning and large-scale computer simulations to identify structu | Health And Medicine ...

Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug ...

Non-opioid therapeutics for chronic pain are urgently required, given that opioids lead to dangerous side effects, addiction and tolerance. Agonists of the type 1 cannabinoid receptor (CB1) show ...

The human body may use the cannabinoid pathway to make placebos effective, according to a Wired report based on a study from Nature Medicine. According to the report, placebo-activated opioid ...

New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may still have pharmaceutical value if researchers could nail down the causes of ...

A synthetic endocannabinoid, the first of its kind, has been created by researchers to be more stable and potent than the ...

In From Bud to Brain, I traced how marijuana research gradually morphed from focusing on the cannabis plant (botany) to exploring the brain’s natural endocannabinoid system (neuroscience) and, ...

A cannabinoid our bodies produce naturally has been found, in a new study, to play a role in the inappropriate regulation of fear responses characteristic of conditions like anxiety and PTSD. The ...